%20copy.jpg)
About
Colleen Cuffaro is a partner at Canaan focused on early-stage biopharmaceutical companies and joined the firm in 2014. She helped launch the Canaan-Yale Fellowship program, serves on the board of the New England Venture Capital Association since 2017, previously worked as a chemist at PMRS, Inc., and holds a Ph.D. from Yale and a B.A. in Chemistry from the University of Pennsylvania.
Colleen Cuffaro @colleencuffaro
THIS is why we do what we do. https://t.co/RhnZbzVIBU
Nov 19, 2020 Β· β₯ 6 Β· β 1
Colleen Cuffaro @colleencuffaro
Congrats to the Tizona team and @nkjellson! https://t.co/hVFKcD6wLI
Jul 21, 2020 Β· β₯ 5
Colleen Cuffaro @colleencuffaro
I remember the day @JuliePapanek first shared her idea for a pediatric oncology company with me. Amazing to witness her relentless pursuit of this noble cause. Congrats to Julie and the whole DayOne team! https://t.co/1Zt6PFOdZ2
May 21, 2020 Β· β₯ 7
Invests in
Biotech
Investments
Investor
Agomab TherapeuticsAlphina TherapeuticsArrakis TherapeuticsCatalYmDraig Therapeutics
As listed on the firm's website.